Integrin β4 promotes DNA damage-related drug resistance in triple-negative breast cancer via TNFAIP2/IQGAP1/RAC1

被引：9
|
作者：
Fang, Huan [1 ,2 ]
Ren, Wenlong [1 ,3 ]
Cui, Qiuxia [1 ,4 ,5 ]
Liang, Huichun [1 ]
Yang, Chuanyu [1 ]
Liu, Wenjing [1 ]
Wang, Xinye [1 ]
Liu, Xue [6 ]
Shi, Yujie [7 ]
Feng, Jing [6 ,8 ,9 ]
Chen, Ceshi [1 ,10 ,11 ]
机构：
[1] Chinese Acad Sci, Kunming Inst Zool, Kunming, Yunnan, Peoples R China
[2] Univ Chinese Acad Sci, Kunming Coll Life Sci, Kunming, Yunnan, Peoples R China
[3] Univ Sci & Technol China, Sch Life Sci, Hefei, Peoples R China
[4] Guangdong Med Univ, Affiliated Hosp, Zhanjiang, Guangdong, Peoples R China
[5] Chinese Acad Med Sci & Peking Union Med Coll, Canc Hosp & Shenzhen Hosp, Natl Clin Res Ctr Canc, Dept Breast Surg Oncol,Natl Canc Ctr, Shenzhen, Guangdong, Peoples R China
[6] Shanghai Univ Med & Hlth Sci, Affiliated Peoples Hosp 6, South Campus, Shanghai 201499, Peoples R China
[7] Zhengzhou Univ, Henan Prov Peoples Hosp, Dept Pathol, Zhengzhou, Peoples R China
[8] Chinese Univ Hong Kong, Affiliated Hosp 2, Shenzhen, Peoples R China
[9] Southern Med Univ, Sch Lab Med & Biotechnol, Guangzhou, Guangdong, Peoples R China
[10] Kunming Med Univ, Acad Biomed Engn, Kunming, Peoples R China
[11] Kunming Med Univ, Affiliated Hosp 3, Kunming, Peoples R China
来源：
ELIFE | 2023年 / 12卷
基金：
国家重点研发计划; 中国国家自然科学基金;
关键词：
ITGB4; TNFAIP2; IQGAP1; RAC1; drug resistance; triple-negative breast cancer; Human; RAC; ACTIVATION; METASTASIS; CARCINOMA; PROTEINS; TNFAIP2; IQGAP1; GENE; AKT;
D O I：
10.7554/eLife.88483
中图分类号：
Q [生物科学];
学科分类号：
07 ; 0710 ; 09 ;
摘要：
Anti-tumor drug resistance is a challenge for human triple-negative breast cancer (TNBC) treatment. Our previous work demonstrated that TNFAIP2 activates RAC1 to promote TNBC cell proliferation and migration. However, the mechanism by which TNFAIP2 activates RAC1 is unknown. In this study, we found that TNFAIP2 interacts with IQGAP1 and Integrin beta 4. Integrin beta 4 activates RAC1 through TNFAIP2 and IQGAP1 and confers DNA damage-related drug resistance in TNBC. These results indicate that the Integrin beta 4/TNFAIP2/IQGAP1/RAC1 axis provides potential therapeutic targets to overcome DNA damage-related drug resistance in TNBC.
引用
收藏
页数：21
相关论文
共 50 条
  • [1] RASAL2 activates RAC1 to promote triple-negative breast cancer progression
    Feng, Min F
    Bao, Yi
    Li, Zhimei
    Li, Juntao
    Gong, Min
    Lam, Stella
    Wang, Jinhua
    Marzese, Diego M.
    Donovan, Nicholas
    Tan, Ern Yu
    Hoon, Dave S. B.
    Yu, Qiang
    JOURNAL OF CLINICAL INVESTIGATION, 2014, 124 (12): : 5291 - 5304
  • [2] Invasively distinct subpopulations cooperate via a laminin-332/Rac1 axis in triple-negative breast cancer
    Yoon, S.
    Mouw, J. K.
    Chen, L.
    Wu, H.
    Marcus, A. I.
    MOLECULAR BIOLOGY OF THE CELL, 2023, 34 (02) : 314 - 315
  • [3] Invasively distinct subpopulations cooperate via a laminin-332/Rac1 axis in triple-negative breast cancer
    Yoon, Sung Bo Joseph
    Mouw, Janna
    Chen, Luxiao
    Wu, Hao
    Marcus, Adam
    CANCER RESEARCH, 2023, 83 (05)
  • [4] TNFAIP2 promotes HIF1α transcription and breast cancer angiogenesis by activating the Rac1-ERK-AP1 signaling axis
    Ren, Wenlong
    Liang, Huichun
    Sun, Jian
    Cheng, Zhuo
    Liu, Wenjing
    Wu, Yingying
    Shi, Yujie
    Zhou, Zhongmei
    Chen, Ceshi
    CELL DEATH & DISEASE, 2024, 15 (11):
  • [5] MLK4 regulates DNA damage response and promotes triple-negative breast cancer chemoresistance
    Dawid Mehlich
    Michał Łomiak
    Aleksandra Sobiborowicz
    Alicja Mazan
    Dagmara Dymerska
    Łukasz M. Szewczyk
    Anna Mehlich
    Agnieszka Borowiec
    Monika K. Prełowska
    Adam Gorczyński
    Paweł Jabłoński
    Ewa Iżycka-Świeszewska
    Dominika Nowis
    Anna A. Marusiak
    Cell Death & Disease, 12
  • [6] MLK4 regulates DNA damage response and promotes triple-negative breast cancer chemoresistance
    Mehlich, Dawid
    Lomiak, Michal
    Sobiborowicz, Aleksandra
    Mazan, Alicja
    Dymerska, Dagmara
    Szewczyk, Lukasz M.
    Mehlich, Anna
    Borowiec, Agnieszka
    Prelowska, Monika K.
    Gorczynski, Adam
    Jablonski, Pawel
    Izycka-Swieszewska, Ewa
    Nowis, Dominika
    Marusiak, Anna A.
    CELL DEATH & DISEASE, 2021, 12 (12)
  • [7] HORMAD1 promotes docetaxel resistance in triple negative breast cancer by enhancing DNA damage tolerance
    Zong, Beige
    Sun, Lu
    Peng, Yang
    Wang, Yihua
    Yu, Yu
    Lei, Jinwei
    Zhang, Yingzi
    Guo, Shipeng
    Li, Kang
    Liu, Shengchun
    ONCOLOGY REPORTS, 2021, 46 (01)
  • [8] Thymosin beta 4 induces colon cancer cell migration and clinical metastasis via enhancing ILK/IQGAP1/Rac1 signal transduction pathway
    Tang, Mei-Chuan
    Chan, Li-Chuan
    Yeh, Yi-Chen
    Chen, Cheng-Yu
    Chou, Teh-Ying
    Wang, Wei-Shu
    Su, Yeu
    CANCER LETTERS, 2011, 308 (02) : 162 - 171
  • [9] DLAT promotes triple-negative breast cancer progression via YAP1 activation
    Liu, Diya
    Wang, Xuehui
    Qian, Fengyuan
    Ye, Danrong
    Deng, Xiaochong
    Fang, Lin
    CANCER BIOLOGY & THERAPY, 2024, 25 (01)
  • [10] The pseudokinase NRBP1 activates Rac1/Cdc42 via P-Rex1 to drive oncogenic signalling in triple-negative breast cancer
    Yang, Xue
    Cruz, Miguel I.
    Nguyen, Elizabeth V.
    Huang, Cheng
    Schittenhelm, Ralf B.
    Luu, Jennii
    Cowley, Karla J.
    Shin, Sung-Young
    Nguyen, Lan K.
    Sian, Terry C. C. Lim Kam
    Clark, Kimberley C.
    Simpson, Kaylene J.
    Ma, Xiuquan
    Daly, Roger J.
    ONCOGENE, 2023, 42 (11) : 833 - 847
12345